Why is Levodopa combined with Carbidopa?

Why is Levodopa combined with Carbidopa?

• A. To inhibit Dopa Decarboxylase from converting Levodopa to Dopamine in periphery
• B. To increase central Dopa Decarboxylase
• C. To block Dopamine receptors
• D. To inhibit Levodopa crossing BBB

Answer: (A)

The main idea is to ensure more levodopa reaches the brain and less dopamine is produced outside the brain. Levodopa is a precursor that can cross the blood-brain barrier, but in the periphery it is rapidly converted to dopamine by DOPA decarboxylase. That peripheral conversion lowers the amount of levodopa that gets into the brain and also causes troublesome side effects from dopamine outside the CNS, like nausea and cardiovascular changes. Carbidopa inhibits the peripheral DOPA decarboxylase, preventing this early conversion. Because carbidopa doesn’t effectively cross the blood-brain barrier, central enzyme activity isn’t inhibited, so levodopa can still be converted to dopamine once inside the brain. This combination allows a smaller, more effective dose of levodopa, with fewer peripheral side effects.

The main idea is to ensure more levodopa reaches the brain and less dopamine is produced outside the brain. Levodopa is a precursor that can cross the blood-brain barrier, but in the periphery it is rapidly converted to dopamine by DOPA decarboxylase. That peripheral conversion lowers the amount of levodopa that gets into the brain and also causes troublesome side effects from dopamine outside the CNS, like nausea and cardiovascular changes. Carbidopa inhibits the peripheral DOPA decarboxylase, preventing this early conversion. Because carbidopa doesn’t effectively cross the blood-brain barrier, central enzyme activity isn’t inhibited, so levodopa can still be converted to dopamine once inside the brain. This combination allows a smaller, more effective dose of levodopa, with fewer peripheral side effects.